$RIGL
RIGEL PHARMACEUTICALS INC

2022 Q4 Form 10-Q Financial Statement

#000155837022016266 Filed on November 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $51.28M $22.41M
YoY Change 151.25% 4.02%
Cost Of Revenue $342.0K $250.0K
YoY Change -29.77% 65.56%
Gross Profit $50.94M $22.16M
YoY Change 155.68% 3.59%
Gross Profit Margin 99.33% 98.88%
Selling, General & Admin $32.17M $25.90M
YoY Change 31.23% 13.2%
% of Gross Profit 63.16% 116.86%
Research & Development $15.37M $14.67M
YoY Change 15.49% -19.86%
% of Gross Profit 30.17% 66.18%
Depreciation & Amortization $284.0K $240.0K
YoY Change -29.7% -8.05%
% of Gross Profit 0.56% 1.08%
Operating Expenses $47.54M $40.56M
YoY Change 25.7% -1.49%
Operating Profit $3.399M -$18.40M
YoY Change -118.99% -6.99%
Interest Expense -$678.0K $826.0K
YoY Change -47.16% -37.28%
% of Operating Profit -19.95%
Other Income/Expense, Net
YoY Change
Pretax Income $1.401M -$19.04M
YoY Change -106.17% -9.73%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $1.401M -$19.04M
YoY Change -106.19% -9.14%
Net Earnings / Revenue 2.73% -84.95%
Basic Earnings Per Share -$0.11
Diluted Earnings Per Share $0.01 -$0.11
COMMON SHARES
Basic Shares Outstanding 172.8M 172.8M
Diluted Shares Outstanding 172.8M

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $58.21M $81.64M
YoY Change -53.42% -42.97%
Cash & Equivalents $24.46M $29.87M
Short-Term Investments $33.75M $51.78M
Other Short-Term Assets $8.259M $6.157M
YoY Change 11.43% 3.79%
Inventory $9.118M $7.116M
Prepaid Expenses
Receivables $40.32M $15.53M
Other Receivables $0.00 $0.00
Total Short-Term Assets $115.9M $110.4M
YoY Change -24.97% -35.45%
LONG-TERM ASSETS
Property, Plant & Equipment $857.0K $1.694M
YoY Change -60.76% -36.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $640.0K $484.0K
YoY Change -34.29% -48.24%
Total Long-Term Assets $18.38M $5.169M
YoY Change 42.88% -66.47%
TOTAL ASSETS
Total Short-Term Assets $115.9M $110.4M
Total Long-Term Assets $18.38M $5.169M
Total Assets $134.3M $115.6M
YoY Change -19.75% -38.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.51M $2.721M
YoY Change 493.1% -13.45%
Accrued Expenses $24.19M $37.26M
YoY Change 575.75% -11.27%
Deferred Revenue $1.369M $1.369M
YoY Change -47.27% -56.64%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $65.21M $47.27M
YoY Change 2.61% -20.27%
LONG-TERM LIABILITIES
Long-Term Debt $39.45M $39.47M
YoY Change 98.09% 98.46%
Other Long-Term Liabilities $42.26M $48.71M
YoY Change -19.84% -10.4%
Total Long-Term Liabilities $42.26M $48.71M
YoY Change -19.84% -10.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $65.21M $47.27M
Total Long-Term Liabilities $42.26M $48.71M
Total Liabilities $147.9M $95.98M
YoY Change 27.19% -15.55%
SHAREHOLDERS EQUITY
Retained Earnings -$1.382B -$1.384B
YoY Change 4.42% 6.35%
Common Stock $1.369B $1.364B
YoY Change 1.08% 0.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$13.62M -$19.83M
YoY Change
Total Liabilities & Shareholders Equity $134.3M $115.6M
YoY Change -19.75% -38.02%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income $1.401M -$19.04M
YoY Change -106.19% -9.14%
Depreciation, Depletion And Amortization $284.0K $240.0K
YoY Change -29.7% -8.05%
Cash From Operating Activities -$21.91M -$13.30M
YoY Change 14.79% 29.17%
INVESTING ACTIVITIES
Capital Expenditures $73.00K -$189.0K
YoY Change 247.62% 11.18%
Acquisitions
YoY Change
Other Investing Activities $18.67M $10.64M
YoY Change 188.71% -124.07%
Cash From Investing Activities $18.60M $10.46M
YoY Change 186.65% -123.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.096M 5.511M
YoY Change -293.18% 1911.31%
NET CHANGE
Cash From Operating Activities -21.91M -13.30M
Cash From Investing Activities 18.60M 10.46M
Cash From Financing Activities -2.096M 5.511M
Net Change In Cash -5.407M 2.665M
YoY Change -53.04% -104.9%
FREE CASH FLOW
Cash From Operating Activities -$21.91M -$13.30M
Capital Expenditures $73.00K -$189.0K
Free Cash Flow -$21.98M -$13.11M
YoY Change 15.05% 29.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0
CY2022Q3 rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
CY2021Q3 rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
dei Entity Registrant Name
EntityRegistrantName
RIGEL PHARMACEUTICALS INC
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001034842
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-29889
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3248524
dei Entity Address Address Line1
EntityAddressAddressLine1
1180 Veterans Blvd.
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
624-1100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
RIGL
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
us-gaap Profit Loss
ProfitLoss
-59974000
CY2021Q4 us-gaap Inventory Net
InventoryNet
6616000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6157000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
106077000
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
172836336
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29866000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18890000
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
51776000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
167328000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15525000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15472000
CY2022Q3 us-gaap Inventory Net
InventoryNet
7116000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7412000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
110440000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
154467000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1694000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2184000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2991000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9703000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
484000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
974000
CY2022Q3 us-gaap Assets
Assets
115609000
CY2021Q4 us-gaap Assets
Assets
167328000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2721000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3795000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8773000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10690000
CY2022Q3 rigl Accrued Research And Development Liability Current
AccruedResearchAndDevelopmentLiabilityCurrent
7574000
CY2021Q4 rigl Accrued Research And Development Liability Current
AccruedResearchAndDevelopmentLiabilityCurrent
10384000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
17602000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12691000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3314000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9892000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1369000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2596000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5912000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13506000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
47265000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
63554000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
759000
CY2022Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
39468000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
19914000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
48710000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
52727000
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
173000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
172000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1364139000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1354190000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-286000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-102000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1383860000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1323886000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-19834000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
30374000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
115609000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
250000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
151000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22410000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172836000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21543000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
68964000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
128827000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1407000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
596000
CY2022Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
14666000
CY2021Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
18300000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
44907000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
51933000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25897000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22877000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
80279000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
67376000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
40813000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
41328000
us-gaap Costs And Expenses
CostsAndExpenses
126593000
us-gaap Costs And Expenses
CostsAndExpenses
119905000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-18403000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-19785000
us-gaap Operating Income Loss
OperatingIncomeLoss
-57629000
us-gaap Operating Income Loss
OperatingIncomeLoss
8922000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
192000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
14000
us-gaap Investment Income Interest
InvestmentIncomeInterest
255000
us-gaap Investment Income Interest
InvestmentIncomeInterest
31000
CY2022Q3 us-gaap Interest Expense
InterestExpense
826000
CY2021Q3 us-gaap Interest Expense
InterestExpense
1317000
us-gaap Interest Expense
InterestExpense
2600000
us-gaap Interest Expense
InterestExpense
3561000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19037000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21088000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59974000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5392000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-136000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
665000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-19037000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-20952000
us-gaap Net Income Loss
NetIncomeLoss
-59974000
us-gaap Net Income Loss
NetIncomeLoss
4727000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170886000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172256000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170297000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172836000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
170886000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172256000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
176452000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19037000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20952000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-59974000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4727000
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
152000
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-184000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
12000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18885000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20951000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-60158000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4739000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
30374000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27445000
CY2022Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-314000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
940000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3243000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
6798000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13492000
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-22000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
599000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2440000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3677000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19037000
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
152000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2728000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-19834000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
34026000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
39500000
CY2021Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
3000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2097000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2672000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
78298000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13821000
CY2021Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
8000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1319000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2306000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
68110000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20952000
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1000
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
274000
us-gaap Profit Loss
ProfitLoss
4727000
us-gaap Share Based Compensation
ShareBasedCompensation
8305000
us-gaap Share Based Compensation
ShareBasedCompensation
7147000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
465000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2237000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
49670000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
714000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
758000
rigl Noncash Interest Expense
NoncashInterestExpense
682000
rigl Noncash Interest Expense
NoncashInterestExpense
2314000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-116000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-171000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
53000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-982000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
394000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5325000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1255000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8113000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-490000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
111000
rigl Increase Decrease Right Of Use Assets
IncreaseDecreaseRightOfUseAssets
6712000
rigl Increase Decrease Right Of Use Assets
IncreaseDecreaseRightOfUseAssets
6071000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-999000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-656000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1917000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-131000
rigl Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
-2810000
rigl Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
4586000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
4911000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2563000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7337000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-6384000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1227000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
139000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
142000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51849000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24964000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
26049000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
117076000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
80062000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
31200000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
543000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
377000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
648000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
54179000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-86524000
rigl Cost Share Advance From Collaboration Partner
CostShareAdvanceFromCollaborationPartner
57900000
rigl Payment Of Cost Share To Collaboration Partner
PaymentOfCostShareToCollaborationPartner
12435000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1539000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3690000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
19542000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8646000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
61590000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30373000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
10976000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170886000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
30000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18890000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29866000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30403000
us-gaap Interest Paid Net
InterestPaidNet
1549000
us-gaap Interest Paid Net
InterestPaidNet
1094000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:9pt 0pt 9pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:9pt 0pt 0pt 0pt;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. We base our </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:9pt;margin:0pt;">estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ from these estimates.</p>
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
81600000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19037000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20952000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-59974000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4727000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172836000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170886000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172256000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170297000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172836000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172256000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170297000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6155000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172836000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
170886000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172256000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
176452000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34259000
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
31037000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34259000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9454000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22410000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21543000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
68964000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
128827000
CY2021Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
7915000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
19650000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
16376000
CY2022Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
11189000
CY2020Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
6065000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
12060000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
10827000
CY2021Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
7298000
rigl Sales Discounts And Allowances
SalesDiscountsAndAllowances
22100000
rigl Sales Discounts And Allowances
SalesDiscountsAndAllowances
13300000
CY2022Q3 rigl Lessee Operating Lease Liability Net Payments
LesseeOperatingLeaseLiabilityNetPayments
1930000
rigl Collaborative Arrangement Upfront Fee Received
CollaborativeArrangementUpfrontFeeReceived
125000000.0
CY2022Q3 us-gaap Accretion Expense
AccretionExpense
0
CY2021Q3 us-gaap Accretion Expense
AccretionExpense
800000
us-gaap Accretion Expense
AccretionExpense
700000
us-gaap Accretion Expense
AccretionExpense
1900000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2707000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2202000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8305000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7147000
CY2022Q1 rigl Extended Exercise Period Number Of Members Of Board Of Directors
ExtendedExercisePeriodNumberOfMembersOfBoardOfDirectors
2
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
800000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
610000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
626000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
5000000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
12353820
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
4555000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
5142000
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1244000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
162000
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1317000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1312000
CY2022Q3 us-gaap Inventory Net
InventoryNet
7116000
CY2021Q4 us-gaap Inventory Net
InventoryNet
6616000
CY2022Q3 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
700000
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
81642000
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
124967000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29866000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18890000
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
51776000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
106077000
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
81642000
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
124967000
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
70139000
CY2022Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
69853000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
111978000
CY2021Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
111876000
rigl Cash Equivalents And Available For Sale Securities Weighted Average Maturity Period
CashEquivalentsAndAvailableForSaleSecuritiesWeightedAverageMaturityPeriod
P105D
CY2021 rigl Cash Equivalents And Available For Sale Securities Weighted Average Maturity Period
CashEquivalentsAndAvailableForSaleSecuritiesWeightedAverageMaturityPeriod
P196D
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
36
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
60194000
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
290000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
100000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5000000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
20000000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
15000000
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
40000000
CY2022Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y3M29D
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1340000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1340000
us-gaap Operating Lease Cost
OperatingLeaseCost
4020000
us-gaap Operating Lease Cost
OperatingLeaseCost
4020000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
211000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
259000
us-gaap Variable Lease Cost
VariableLeaseCost
602000
us-gaap Variable Lease Cost
VariableLeaseCost
651000
CY2022Q3 us-gaap Lease Cost
LeaseCost
1551000
CY2021Q3 us-gaap Lease Cost
LeaseCost
1599000
us-gaap Lease Cost
LeaseCost
4622000
us-gaap Lease Cost
LeaseCost
4671000
CY2022Q3 rigl Sublease Payments To Be Received
SubleasePaymentsToBeReceived
1577000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
2630000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
2529000
us-gaap Operating Lease Payments
OperatingLeasePayments
7856000
us-gaap Operating Lease Payments
OperatingLeasePayments
7554000
CY2022Q3 rigl Fixed Sublease Expense
FixedSubleaseExpense
1095000
CY2021Q3 rigl Fixed Sublease Expense
FixedSubleaseExpense
1095000
rigl Fixed Sublease Expense
FixedSubleaseExpense
3285000
rigl Fixed Sublease Expense
FixedSubleaseExpense
3285000
CY2022Q3 rigl Variable Sublease Expense
VariableSubleaseExpense
232000
CY2021Q3 rigl Variable Sublease Expense
VariableSubleaseExpense
236000
rigl Variable Sublease Expense
VariableSubleaseExpense
682000
rigl Variable Sublease Expense
VariableSubleaseExpense
680000
CY2022Q3 us-gaap Sublease Income
SubleaseIncome
1327000
CY2021Q3 us-gaap Sublease Income
SubleaseIncome
1331000
us-gaap Sublease Income
SubleaseIncome
3967000
us-gaap Sublease Income
SubleaseIncome
3965000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2630000
CY2022Q3 rigl Sublease Payments To Be Received Remainder Of Fiscal Year
SubleasePaymentsToBeReceivedRemainderOfFiscalYear
1183000
CY2022Q3 rigl Lessee Operating Lease Liability Net Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityNetPaymentsRemainderOfFiscalYear
1447000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
877000
CY2022Q3 rigl Sublease Payments To Be Received Next Twelve Months
SubleasePaymentsToBeReceivedNextTwelveMonths
394000
CY2022Q3 rigl Lessee Operating Lease Liability Net Payments Next Twelve Months
LesseeOperatingLeaseLiabilityNetPaymentsNextTwelveMonths
483000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3507000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000

Files In Submission

Name View Source Status
0001558370-22-016266-index-headers.html Edgar Link pending
0001558370-22-016266-index.html Edgar Link pending
0001558370-22-016266.txt Edgar Link pending
0001558370-22-016266-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rigl-20220930.xsd Edgar Link pending
rigl-20220930x10q.htm Edgar Link pending
rigl-20220930x10q004.jpg Edgar Link pending
rigl-20220930xex10d1.htm Edgar Link pending
rigl-20220930xex10d2.htm Edgar Link pending
rigl-20220930xex10d2001.jpg Edgar Link pending
rigl-20220930xex31d1.htm Edgar Link pending
rigl-20220930xex31d2.htm Edgar Link pending
rigl-20220930xex32d1.htm Edgar Link pending
Show.js Edgar Link pending
rigl-20220930_def.xml Edgar Link unprocessable
rigl-20220930_cal.xml Edgar Link unprocessable
rigl-20220930_lab.xml Edgar Link unprocessable
rigl-20220930_pre.xml Edgar Link unprocessable
rigl-20220930x10q_htm.xml Edgar Link completed